In one paragraphArticle in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Sara MilojevicDepartment of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0001-8280-3015 Arijit GhoshChronobiology and Behavioral Neurogenetics Laboratory, Neuroscience Unit, Jawaharlal Nehru Center for Advanced Scientific Research, Jakkur, Bangalore 560064, India.ORCID 0000-0002-7910-3170 Vedrana MakevicDepartment of Pathophysiology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.
Maja StojkovicDepartment of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-0706-3800 Maria CapovillaUMR7275 CNRS-INSERM-UniCA, Institute of Cellular and Molecular Pharmacology Institute, Sophia Antipolis, 06560 Valbonne, France.ORCID 0000-0002-1308-7964 Tomislav TostiInstitute of Chemistry, Technology and Metallurgy, National Institute of the Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-1403-4688 Dejan BudimirovicDepartment of Psychiatry, Fragile X Clinic, Kennedy Krieger Institute, Baltimore, MD 21205, USA.ORCID 0000-0001-7263-5134 Dragana ProticDepartment of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.ORCID 0000-0002-2137-5405 Funding
Science Fund of the Republic of Serbia Program IDEA, GRANT No. 7673781The Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-66/2024-03/200110
6 · The paper itselfAbstract
Fragile X syndrome (FXS) is caused by the full mutation in the
Indexed as
Circadian RhythmDisease Models, AnimalDrosophila melanogasterFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeSleepAnimalsBehavior, AnimalDrosophila ProteinsFemaleMaleMutationVideo RecordingDrosophila ProteinsFMR1 protein, DrosophilaFragile X Messenger Ribonucleoprotein 1circadian rhythmDrosophila melanogaster model of fragile X syndromeFMR1 geneFragile X syndromesleep
Identifiers
PMID39063191
PMCPMC11277495
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390